✦ LIBER ✦

Clostridium difficile-related pancolitis in lung-transplanted patients with cystic fibrosis

✍ Scribed by F. Patriarchi; M. Rolla; F. Maccioni; A. Menichella; C. Scacchi; A. Ambrosini; A. Costantino; S. Quattrucci

Book ID: 110890436
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 237 KB
Volume: 25
Category: Article
ISSN: 0902-0063
DOI: 10.1111/j.1399-0012.2010.01316.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clostridium difficile colitis in cystic

Clostridium difficile colitis in cystic fibrosis patients with and without lung transplantation

✍ C. Theunissen; C. Knoop; C. Nonhoff; B. Byl; M. Claus; C. Liesnard; M.J. Estenne 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Voriconazole pharmacokinetic variability

Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients

✍ M. Berge; R. Guillemain; V. Boussaud; M.-H. Pham; P. Chevalier; A. Batisse; C. A 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

Spondylodiscitis after bilateral sequent

Spondylodiscitis after bilateral sequential lung transplantation in a patient with cystic fibrosis

✍ S. Quattrucci; P. Canuzzi; S. Bertasi; A.D. Grzejdziak; F. Midulla; G. Crucitti; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB

Distal Intestinal Obstruction Syndrome (

Distal Intestinal Obstruction Syndrome (DIOS) in Patients with Cystic Fibrosis After Lung Transplantation

✍ Jonathan R. Morton; Nabila Ansari; Allan R. Glanville; Alan P. Meagher; Reginald 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 198 KB

Tobramycin pharmacokinetics in patients

Tobramycin pharmacokinetics in patients with cystic fibrosis before and after bilateral lung transplantation

✍ K.A. Walsh; G.A. Davis; D. Jr Hayes; R.J. Kuhn; K.A. Weant; J.D. Flynn 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Cyclosporin pharmacokinetics in heart-lu

Cyclosporin pharmacokinetics in heart-lung transplant recipients with cystic fibrosis

✍ V. T. Tsang; A. Johnston; F. Heritier; N. Leaver; M. E. Hodson; M. Yacoub 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 529 KB

Cyclosporin (CsA) is currently the main immunosuppressive agent used in organ transplantation with considerable improvement in graft survival. Oral CsA solution is highly lipophilic, and its bioavailability may be reduced in cystic fibrosis (CF) heart-lung transplant recipients with pancreatic, gas